{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:57:45Z","timestamp":1784030265682,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Estrogen receptor-positive (ER\u207a) breast cancer is commonly treated with hormone therapy; however, these tumors frequently develop drug resistance and exhibit poor responses to radiotherapy. To investigate the molecular basis of therapy resistance, we explored the role of estrogen receptor alpha (ESR1) in modulating sensitivity to oxidative and radiation stress. Through integrative analysis of publicly available datasets, we identified ESR1 as a key molecular marker associated not only with breast cancer classification but also with radiosensitivity. In ER\u207a breast cancer cell lines, higher endogenous ESR1 expression correlated with increased resistance to ionizing radiation. Functional studies using ESR1 overexpression and knockdown models revealed that depletion of ESR1 sensitized cells to radiation-induced DNA damage, impaired DNA repair efficiency, and reduced clonogenic survival. Notably, we found that the ESR1\u2013SQSTM1 (p62) interaction impairs autophagic flux, contributing to treatment resistance. Mechanistically, ESR1 translocates to the cytoplasm and binds to SQSTM1, thereby disrupting autophagosome maturation. Furthermore, estradiol enhances ESR1 phosphorylation and its affinity for SQSTM1, reinforcing this inhibitory effect on autophagy and promoting resistance to radiation. Our findings uncover a previously unrecognized ESR1\u2013SQSTM1 axis that governs autophagy and redox response in ER\u207a breast cancer. Targeting this pathway may restore sensitivity to radiotherapy and offer a new therapeutic strategy. Assessment of ESR1 expression and autophagy activity may serve as predictive biomarkers for treatment response in ER\u207a breast cancer patients.<\/jats:p>","DOI":"10.1038\/s41420-025-02755-8","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:25:16Z","timestamp":1759843516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-3156","authenticated-orcid":false,"given":"Yi-Fang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Hsi","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-0714","authenticated-orcid":false,"given":"Cheorl-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-1669","authenticated-orcid":false,"given":"Chi-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-9213","authenticated-orcid":false,"given":"Michael","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-1893","authenticated-orcid":false,"given":"Ying-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Mu-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-9935","authenticated-orcid":false,"given":"Yu-Chan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2755_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2755_CR2","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jfma.2019.08.023","volume":"119","author":"CN Kuo","year":"2020","unstructured":"Kuo CN, Liao YM, Kuo LN, Tsai HJ, Chang WC, Yen Y. Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost. J Formos Med Assoc. 2020;119:1731\u201341.","journal-title":"J Formos Med Assoc"},{"key":"2755_CR3","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1158\/1055-9965.EPI-08-0109","volume":"17","author":"KD Lee","year":"2008","unstructured":"Lee KD, Chen SC, Chan CH, Lu CH, Chen CC, Lin JT, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomark Prev. 2008;17:2647\u201355.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2755_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-86","volume":"10","author":"R Sabatier","year":"2011","unstructured":"Sabatier R, Finetti P, Mamessier E, Raynaud S, Cervera N, Lambaudie E, et al. Kinome expression profiling and prognosis of basal breast cancers. Mol Cancer. 2011;10:86.","journal-title":"Mol Cancer"},{"key":"2755_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3121\/cmr.2008.825","volume":"7","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009;7:4\u201313.","journal-title":"Clin Med Res"},{"key":"2755_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819555","volume":"12","author":"PS Yang","year":"2022","unstructured":"Yang PS, Chao YT, Lung CF, Liu CL, Chang YC, Li KC, et al. Association of pathway mutations with survival in Taiwanese breast cancers. Front Oncol. 2022;12:819555.","journal-title":"Front Oncol"},{"key":"2755_CR7","first-page":"1339","volume":"81","author":"KL Maughan","year":"2010","unstructured":"Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. Am Fam Physician. 2010;81:1339\u201346.","journal-title":"Am Fam Physician"},{"key":"2755_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.839005","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Front Endocrinol (Lausanne). 2022;13:839005.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2755_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00397-y","volume":"8","author":"AR Michmerhuizen","year":"2022","unstructured":"Michmerhuizen AR, Lerner LM, Pesch AM, Ward C, Schwartz R, Wilder-Romans K, et al. Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. NPJ Breast Cancer. 2022;8:31.","journal-title":"NPJ Breast Cancer"},{"key":"2755_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1677\/erc.1.00776","volume":"11","author":"A Ring","year":"2004","unstructured":"Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11:643\u201358.","journal-title":"Endocr Relat Cancer"},{"key":"2755_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3127-9_1","volume":"1366","author":"KM Eyster","year":"2016","unstructured":"Eyster KM. The estrogen receptors: an overview from different perspectives. Methods Mol Biol. 2016;1366:1\u201310.","journal-title":"Methods Mol Biol"},{"key":"2755_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cells8101123","volume":"8","author":"ZR Tang","year":"2019","unstructured":"Tang ZR, Zhang R, Lian ZX, Deng SL, Yu K. Estrogen-receptor expression and function in female reproductive disease. Cells. 2019;8:1123.","journal-title":"Cells"},{"key":"2755_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.critrevonc.2004.02.001","volume":"51","author":"N Platet","year":"2004","unstructured":"Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol. 2004;51:55\u201367.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2755_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.21614\/chirurgia.112.4.413","volume":"112","author":"M Dr\u0103g\u0103nescu","year":"2017","unstructured":"Dr\u0103g\u0103nescu M, Carmocan C. Hormone therapy in breast cancer. Chirurgia (Bucur). 2017;112:413\u20137.","journal-title":"Chirurgia (Bucur)"},{"key":"2755_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11154-007-9034-4","volume":"8","author":"RF Swaby","year":"2007","unstructured":"Swaby RF, Sharma CG, Jordan VC. SERMs for the treatment and prevention of breast cancer. Rev Endocr Metab Disord. 2007;8:229\u201339.","journal-title":"Rev Endocr Metab Disord"},{"key":"2755_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"HK Patel","year":"2018","unstructured":"Patel HK, Bihani T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharm Ther. 2018;186:1\u201324.","journal-title":"Pharm Ther"},{"key":"2755_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.599586","volume":"12","author":"EB Belachew","year":"2021","unstructured":"Belachew EB, Sewasew DT. Molecular mechanisms of endocrine resistance in estrogen-positive breast cancer. Front Endocrinol (Lausanne). 2021;12:599586.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2755_CR18","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.1111\/jcmm.16946","volume":"25","author":"Y Li","year":"2021","unstructured":"Li Y, Kong X, Xuan L, Wang Z, Huang YH. Prolactin and endocrine therapy resistance in breast cancer: the next potential hope for breast cancer treatment. J Cell Mol Med. 2021;25:10327\u201348.","journal-title":"J Cell Mol Med"},{"key":"2755_CR19","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2013;14:1086\u201394.","journal-title":"Lancet Oncol"},{"key":"2755_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet"},{"key":"2755_CR21","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, et al. Internal mammary and medial supraclavicular. Lancet Oncol. 2020;21:1602\u201310.","journal-title":"Lancet Oncol"},{"key":"2755_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320.","journal-title":"N Engl J Med"},{"key":"2755_CR23","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1002\/cncr.32345","volume":"125","author":"D Dustin","year":"2019","unstructured":"Dustin D, Gu G, Fuqua SAW. ESR1 mutations in breast cancer. Cancer. 2019;125:3714\u201328.","journal-title":"Cancer"},{"key":"2755_CR24","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1038\/onc.2012.556","volume":"32","author":"O Surova","year":"2013","unstructured":"Surova O, Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene. 2013;32:3789\u201397.","journal-title":"Oncogene"},{"key":"2755_CR25","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3892\/or.2016.4752","volume":"35","author":"L Cui","year":"2016","unstructured":"Cui L, Song Z, Liang B, Jia L, Ma S, Liu X. Radiation induces autophagic cell death via the p53\/DRAM signaling pathway in breast cancer cells. Oncol Rep. 2016;35:3639\u201347.","journal-title":"Oncol Rep"},{"key":"2755_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/15384047.2015.1046022","volume":"16","author":"D Zhang","year":"2015","unstructured":"Zhang D, Tang B, Xie X, Xiao YF, Yang SM, Zhang JW. The interplay between DNA repair and autophagy in cancer therapy. Cancer Biol Ther. 2015;16:1005\u201313.","journal-title":"Cancer Biol Ther"},{"key":"2755_CR27","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/ijms18122749","volume":"18","author":"W Hur","year":"2017","unstructured":"Hur W, Yoon SK. Molecular pathogenesis of radiation-induced cell toxicity in stem cells. Int J Mol Sci. 2017;18:2741.","journal-title":"Int J Mol Sci"},{"key":"2755_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","volume":"44","author":"G Matsumoto","year":"2011","unstructured":"Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 2011;44:279\u201389.","journal-title":"Mol Cell"},{"key":"2755_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03442-z","volume":"12","author":"L Wang","year":"2021","unstructured":"Wang L, Sun J, Yin Y, Sun Y, Ma J, Zhou R, et al. Transcriptional coregulator NUPR1 maintains tamoxifen resistance in breast cancer cells. Cell Death Dis. 2021;12:149.","journal-title":"Cell Death Dis"},{"key":"2755_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HP.0000000000001601","volume":"123","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Cao F, Liu H. Radiation-induced cell death and its mechanisms. Health Phys. 2022;123:376\u201386.","journal-title":"Health Phys"},{"key":"2755_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49.","journal-title":"Signal Transduct Target Ther"},{"key":"2755_CR32","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.12659\/MSM.904810","volume":"23","author":"X Chen","year":"2017","unstructured":"Chen X, Ma N, Zhou Z, Wang Z, Hu Q, Luo J, et al. Estrogen receptor mediates the radiosensitivity of triple-negative breast cancer cells. Med Sci Monit. 2017;23:2674\u201383.","journal-title":"Med Sci Monit"},{"key":"2755_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"2755_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0179-2","volume":"6","author":"G Nassa","year":"2019","unstructured":"Nassa G, Giurato G, Salvati A, Gigantino V, Pecoraro G, Lamberti J, et al. The RNA-mediated estrogen receptor \u03b1 interactome of hormone-dependent human breast cancer cell nuclei. Sci Data. 2019;6:173.","journal-title":"Sci Data"},{"key":"2755_CR35","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1096\/fj.202000520R","volume":"34","author":"B Liu","year":"2020","unstructured":"Liu B, Chen G, He Q, Liu M, Gao K, Cai B, et al. An HMGA2-p62-ER\u03b1 axis regulates uterine leiomyomas proliferation. FASEB J. 2020;34:10966\u201383.","journal-title":"FASEB J"},{"key":"2755_CR36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/jpm11080812","volume":"11","author":"CL Tsai","year":"2021","unstructured":"Tsai CL, Lin CY, Chao A, Lee YS, Wu RC, Tsai CN, et al. GPR30 activation by 17\u03b2-estradiol promotes p62 phosphorylation. J Pers Med. 2021;11:812.","journal-title":"J Pers Med"},{"key":"2755_CR37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/1878-0261.12483","volume":"13","author":"IX Perez-A\u00f1orve","year":"2019","unstructured":"Perez-A\u00f1orve IX, Gonzalez-De la Rosa CH, Soto-Reyes E, Beltran-Anaya FO, Del Moral-Hernandez O, Salgado-Albarran M, et al. New insights into radioresistance in breast cancer. Mol Oncol. 2019;13:1249\u201367.","journal-title":"Mol Oncol"},{"key":"2755_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109299","volume":"725","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang C, Qu S, Liu R, Chen H, Liang Z, et al. ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L\/CD71 pathway. Arch Biochem Biophys. 2022;725:109299.","journal-title":"Arch Biochem Biophys"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02755-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T02:02:48Z","timestamp":1759888968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02755-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2755"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02755-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the institutional review board and ethics committee (YM109173W) of National Yang Ming Chiao Tung University. All procedures were conducted in accordance with relevant guidelines. Informed consent was obtained from all individual participants included in the study. All animal procedures were approved by the Institutional Animal Care and Use Committee of the Academia Sinica (Approval Number: IACUC_21-12-1744).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"451"}}